As you may have learned recently, the "Magnificent Seven" is a group of powerhouse stocks including Nvidia, Apple, and , most of which have benefited significantly from the enthusiasm surrounding their artificial intelligence (AI) efforts. But which would be the equivalent businesses if the same concept were applied to the healthcare sector rather than the technology sector?

As it turns out, there are only four stocks that have the right combination of ongoing growth and market-outperforming returns. All four of these magnificent healthcare companies have solid business models, upwardly trending share prices, and, unfortunately, somewhat frothy valuations.

But they also have very long growth runways and a history of good execution, so there's a solid chance that their price tags will be justified by continued strong performance. Let's meet the players.

Continue reading

Source Fool.com